OS Therapies names Kerry Clem chief commercial officer

Bitget2026/10/01 12:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

OS Therapies appointed Kerry Clem as chief commercial officer to lead U.S., U.K., and European launch planning for Herlystic.
Clem previously served as CEO of Solaxa, was CCO at Acorda Therapeutics, held commercial roles at Allos Therapeutics.
Frank Knuettel II was named chief financial officer as OS Therapies prepares to shift from development-stage to commercialization.
Knuettel was CFO of Pelthos Therapeutics, was CEO of Channel Therapeutics, led more than 15 M&A deals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OS Therapies Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610010830NEWSFILECNPR____20261001_316882_1) on October 01, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OS Therapies names Kerry Clem chief commercial officer

You may also like

Crypto prices